Ilsung Pharmaceuticals Co. Ltd. (KOSE:A003120) seeks to sell stake in Samsung C&T Corporation (KOSE:A000830). Ilsung plans to sell 3.31 million shares of Samsung C&T for KRW 189.28 billion.

The expected transaction settlement date is August 27, 2015.